Abingdon Health has signed a new distribution agreement with Israeli company Salignostics to launch the latter’s Salistick saliva-based pregnancy test in Ireland and the UK.

Under the terms of the agreement, Abingdon Health will co-brand Salistick under its Abingdon Simply Test and sell it through its direct-to-consumer eCommerce platform as well as the company’s other pharmacy distribution channels.

The quick saliva-based pregnancy test offers users a new, improved experience and high accuracy early pregnancy detection.

It is based on Salignostics’ technology, which has been designed to detect the pregnancy hormone β-hCG in saliva.

The new test, which is CE-marked, offers the ability to perform a pregnancy test at any time as well as anywhere.

It is anticipated to receive UK regulatory approval and become available in the second quarter of the year.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Abingdon Health CEO Chris Yates said: “We are delighted to be distributing Salistick in the UK and Ireland, the first saliva pregnancy test to be launched worldwide.

“This exciting innovation offers women the opportunity to test for pregnancy in a cleaner, more straightforward and easier way, and is a long overdue development in the pregnancy testing market.

“We are excited to be partnering with Salignostics and we look forward to continuing to work with them to bring innovative self-test products to market.”

Currently, the company’s Abingdon Simply Test range includes more than 14 home-use lateral flow self-tests, which are sold direct-to-consumer through the Abingdon Simply Test website.

Abingdon Health intends to continue expanding the innovative self-test range through collaborations with innovative companies, such as Salignostics, allowing the company to bring new self-test technologies to the market.